Fulgent Genetics Profit Margin 2015-2023 | FLGT
Current and historical gross margin, operating margin and net profit margin for Fulgent Genetics (FLGT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Fulgent Genetics net profit margin as of December 31, 2023 is -58.03%.
| Fulgent Genetics Annual Profit Margins |
|---|
| Fulgent Genetics Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.601B | $0.289B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.774B | 21.57 |
| Inspire Medical Systems (INSP) | United States | $7.306B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.489B | 0.00 |
| 10x Genomics (TXG) | United States | $3.450B | 0.00 |
| Axonics (AXNX) | United States | $3.420B | 0.00 |
| Enovis (ENOV) | United States | $3.031B | 23.03 |
| Azenta (AZTA) | United States | $2.816B | 229.50 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.769B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.644B | 0.00 |
| Privia Health (PRVA) | United States | $2.114B | 93.79 |
| Schrodinger (SDGR) | United States | $1.760B | 0.00 |
| Phreesia (PHR) | United States | $1.275B | 0.00 |
| Omnicell (OMCL) | United States | $1.251B | 30.62 |
| Definitive Healthcare (DH) | United States | $0.829B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Talkspace (TALK) | United States | $0.502B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.313B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.313B | 0.00 |
| Pulmonx (LUNG) | United States | $0.289B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| American Well (AMWL) | United States | $0.150B | 0.00 |
| Augmedix (AUGX) | United States | $0.147B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.06 |
| Outset Medical (OM) | United States | $0.116B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.115B | 0.00 |
| 111 (YI) | China | $0.084B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.075B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Akili (AKLI) | United States | $0.018B | 0.00 |
| Biotricity (BTCY) | United States | $0.014B | 0.00 |
| Centogene (CNTG) | Germany | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |